Improving predictions of health risks for patients on hemodialysis
Official title: Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factors
Funded at Icahn School of Medicine at Mount Sinai · NIH-10991307 · Data updated 2026-11-12
This study is looking to improve how we predict health issues for people on hemodialysis by considering important social factors, like access to healthcare and personal circumstances, to help doctors provide better care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | January 15, 2021 |
| Project end | November 30, 2025 |
| Funding year | 2025 |
| Award (this year) | $190,147 |
| NIH project number | 5K23DK124645-05 |
| Project ID | NIH-10991307 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients currently receiving hemodialysis treatment who may be affected by social determinants of health.
✕Less likely to help
Patients who are not on hemodialysis or those with conditions unrelated to the factors being studied may not benefit from this research.
What this research studies
This research aims to enhance the prediction of adverse health outcomes for patients undergoing hemodialysis by integrating non-traditional risk factors, particularly social determinants of health. The study utilizes electronic health records (EHR) to analyze various factors that may influence patient health, such as access to healthcare and psychosocial elements. By employing advanced statistical methods and machine learning techniques, the research seeks to develop more accurate risk assessment tools that can ultimately guide better patient care and management.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes for hemodialysis patients by enabling more personalized and effective treatment strategies.
How similar studies have gone: Other research has shown success in using social determinants of health to improve patient outcomes, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Chan, Lili — Icahn School of Medicine at Mount Sinai
- Study coordinator: Chan, Lili
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
ALS risk factors in a long-term ALS study
A long-term ALS study is looking at which factors may influence disease risk and progression in people living with ALS.
-
Understanding how work exposures and genes influence ALS risk
A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetic, behavior, and vascular data
Aims to predict Alzheimer’s disease risk in middle-aged South Asians by combining genetic, lifestyle, and vascular information to catch early changes before dementia develops.
-
P-CARRS-BRAIN: Predicting Alzheimer’s risk in South Asians in India using genetics, behavior, and vascular data
Aimed at people 21 and older, this project looks at how biology, behavior, and blood vessel health together may signal the early risk of Alzheimer’s disease and related dementias in South Asians.
-
Understanding how risk factors affect progression of cirrhosis and response to statins in patients with cirrhosis
This project follows people with cirrhosis to see what factors speed up their liver disease and whether statin medicines help prevent worsening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.